2-Bromo-9,9-difluoro-9H-fluorene, 98%, 100mg

4-Chlorophenyl acetic acid ethyl ester, 95.0%, 25g

1-(9H-Fluoren-9-yl)-3,14-dioxo-2,7,10-trioxa-4,13-diazaheptadecan-17-oic acid, 95%, 25g

4-(4-Hydroxy-3-methoxyphenyl)but-3-en-2-one, 98.0%, 10g

3-Methyl-2-oxazolidone>99.0%(GC)100g

Colonne HPLC NUCLEODUR® NH2-RP 5 µm, 125 mm, 4 mm, 1 pièce(s)

Galunisertib, 95.0%, 100mg

Imidazole, 50 g

4,4'-BIS(OXIRAN-2-YLMETHYL)-1,1'-BIPHENYL, 95.0%, 250mg

1,2,3-Tri-O-acetyl-5-deoxy-beta-D-ribofuranose>98.0%(GC)25g

[1,1':3',1''-Terphenyl]-3,3'',5,5',5''-pentacarboxylic acid, 97%, 250mg

[(2H-1,3-benzodioxol-5-yl)methyl](prop-2-en-1-yl)amine, 95.0%, 1g

2,6-Dichloroquinoline>98.0%(GC)1g